Zongertinib Trial in HER2 Aberrant Tumors
Zongertinib (BI.1810631) Phase I Study in Advanced Solid Tumors with HER2 Aberrations focusing on NSCLC. The trial involves dose escalation and expansion, testing different doses in cohorts with varied HER2 mutations. Primary endpoints include MTD, OR, and DLTs.
2 views • 14 slides
Titration Colour Changes
This collection features various experiments in chemistry involving titration and solutions. It includes procedures such as standardizing hydrochloric acid using sodium carbonate, titrating hydrochloric acid with sodium hydroxide to produce sodium chloride, determining the concentration of ethanoic
0 views • 10 slides
OCTIVUS Randomized Clinical Trial: OCT-Guided vs IVUS-Guided PCI
The OCTIVUS Randomized Clinical Trial compared the clinical efficacy and safety of Optical Coherence Tomography (OCT)-guided and Intravascular Ultrasound (IVUS)-guided strategies in patients undergoing PCI for significant CAD. The study aimed to determine if OCT-guided PCI is noninferior to IVUS-gui
8 views • 27 slides
ARREST Trial: Expedited Transfer for Non-ST Elevation OHCA
This prospective, multicentre, randomised clinical trial led by Dr. Tiffany Patterson aims to determine whether direct delivery to a cardiac arrest centre following non-ST elevation out-of-hospital cardiac arrest reduces deaths compared to delivery to the nearest emergency department. Funded by the
0 views • 17 slides
Comprehensive Bug Hunting Toolkit for Cybersecurity Enthusiasts
Explore a detailed guide on bug hunting tools, techniques, and resources by expert bug hunter Orwa Atyat from Jordan. Learn valuable tips on finding high/critical bugs, conducting basic recon, subdomain enumerations, collecting URLs/endpoints, and searching for backup files. Enhance your cybersecuri
2 views • 14 slides
Efficacy and Safety of Ferric Carboxymaltose for Heart Failure with Iron Deficiency
Iron deficiency is prevalent in heart failure patients with reduced ejection fraction and is linked to poor outcomes. The HEART-FID trial investigates the impact of intravenous ferric carboxymaltose (FCM) on all-cause mortality, heart failure hospitalizations, and exercise capacity in chronic HFrEF
1 views • 17 slides
SISTER Study: Improving Stroke Treatment Response with TS23
SISTER Study led by Eva Mistry aims to identify a safe and effective dose of TS23 for treating ischemic stroke patients with core-penumbra mismatch. The Phase-2 trial involves 300 adults and spans 54 months, with primary endpoints focusing on treatment efficacy and safety. The study is randomized, p
0 views • 22 slides
Extracorporeal Life Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock
This study explores the use of extracorporeal life support (ECLS) in patients with acute myocardial infarction complicated by cardiogenic shock. The researchers investigate the impact of ECLS on mortality and various secondary endpoints such as renal failure, recurrent infarction, and need for revas
0 views • 20 slides
Optimal First Line Therapy for Metastatic Melanoma: Nivolumab and Relatlimab
Discussing the efficacy and safety of Nivolumab and Relatlimab as a superior first-line therapy option for newly diagnosed metastatic melanoma patients, with comparisons to other treatments based on key endpoints and tolerability data presented at ASCO Annual Meeting.
0 views • 8 slides
Overview of Cohort Studies in Epidemiology
Cohort studies are a type of observational study where a group of healthy subjects is followed over time to investigate relationships between exposures and outcomes. They provide valuable insights into disease development and risk factors, offering advantages like assessing multiple exposures and en
0 views • 21 slides
Understanding Pharmaceutical Degradation: Types and Factors
Pharmaceutical degradation refers to the process of a formulation in a specific container losing its chemical, microbiological, therapeutic, physical, and toxicological specifications. It can be categorized into physical, chemical, and microbiological degradation. Physical degradation alters the dru
1 views • 50 slides
Digital Health Technology-Derived Clinical Outcome Assessments in Regulatory Decision-Making
This session discusses the landscape of DHT-derived novel endpoints in clinical research, focusing on considerations for regulatory decision-making. It explains the use of digital health technology in clinical outcome assessments and highlights the potential benefits of digitally collected COAs, suc
0 views • 42 slides
Empagliflozin Effects on Heart Failure with Reduced Ejection Fraction: EMPEROR-Reduced Trial Overview
Empagliflozin's impact on cardiovascular and renal events in heart failure with reduced ejection fraction was assessed in the EMPEROR-Reduced trial led by Milton Packer, MD, and Faiez Zannad, MD. The trial, enriched for patients with severe left ventricular dysfunction, randomized participants to em
2 views • 22 slides
Understanding Statistical Methods for Clinical Endpoints in Diabetes Research
This educational slide module delves into fundamental statistics for analyzing clinical endpoints in diabetes research. It covers the choice of statistical methods, the distinction between statistical and clinical significance, and the importance of different endpoints in evaluating clinical benefit
1 views • 37 slides
Comparison of FFR-guided PCI vs Angiography-guided PCI in AMI with Multivessel Disease: FRAME-AMI Trial
In patients with acute myocardial infarction (AMI) and multivessel coronary artery disease, this study aims to compare fractional flow reserve (FFR)-guided PCI with angiography-guided PCI for non-infarct-related artery lesions. The hypothesis is that selective PCI guided by FFR is superior to routin
2 views • 23 slides
Understanding the Fundamental Theorem of Calculus
The Fundamental Theorem of Calculus states that if a function is continuous on an interval and has an antiderivative on that interval, then the integral of the function over the interval is equal to the difference of the antiderivative evaluated at the endpoints. This concept is further explored thr
0 views • 14 slides
Understanding Postmortem Redistribution in Forensic Toxicology
Postmortem Redistribution (PMR) refers to the variation in drug concentrations obtained from postmortem samples, which may not accurately reflect the levels at the time of death due to redistribution mechanisms. In forensic toxicology, assessing drug severity relies on blood concentrations, with cha
0 views • 16 slides
Back Titration in Analytical Chemistry
Back titration is a technique used in analytical chemistry to determine the concentration of an analyte by reacting it with an excess of another reagent first, followed by titration of the excess reactant. This method is especially useful in cases where direct titration endpoints are difficult to di
2 views • 14 slides
Digital Differential Analyzer (DDA) Algorithm in Computer Graphics
In computer graphics, the Digital Differential Analyzer (DDA) Algorithm is utilized as the basic line drawing algorithm. This method involves interpolation of variables between two endpoints to rasterize lines, triangles, and polygons efficiently. The algorithm requires inputting coordinates of two
0 views • 9 slides
Molecularly-Guided Therapy vs Platinum Chemotherapy in CUP Patients
This trial aims to compare the efficacy and safety of molecularly-guided therapy or cancer immunotherapy based on genomic profiling with platinum-based chemotherapy in patients with cancer of unknown primary site. The study design includes multiple treatment regimens guided by genomic profiles, with
4 views • 9 slides
Enhancing User Productivity with Outlook Actionable Messages
Explore how to develop and deploy Outlook Actionable Messages to optimize user productivity. Join Julie Turner, a seasoned professional developer, in learning about connectors, message creation, API endpoints, security, and more, to create targeted and interactive messages within Outlook. Get a hand
0 views • 18 slides
Challenges and Recommendations for DHT-derived Endpoints in Clinical Trials
This study by CTTI explores barriers and solutions for adopting digitally derived endpoints in clinical trials. Through in-depth interviews with industry sponsors, the research identifies gaps, barriers, and recommendations for using DHT-derived novel endpoints as key endpoints in pivotal clinical t
0 views • 16 slides
Advances in Aortic Valve Development and TAVR Trials
The presentation discusses various endpoints in aortic valve development and Transcatheter Aortic Valve Replacement (TAVR) trials, including comparisons, study stages, and newer devices. It covers different trial populations, primary and secondary endpoints, and the evaluation of non-inferiority. Su
0 views • 18 slides
Comparison of Valve Types and Anesthesia Strategies in Transcatheter Aortic Valve Implantation
In the SOLVE-TAVI trial, patients undergoing transcatheter aortic valve implantation were randomized to receive either self-expandable or balloon-expandable valves under general or local anesthesia. The study aims to compare the effectiveness and safety of different valve types and anesthesia approa
0 views • 27 slides
Understanding Immunotoxicity in Fish: An Alternative Model for Toxicological Studies
The study explores the immunotoxic effects of industrial effluents on fin fish, highlighting xenobiotics' impact on the immune system. It discusses the sensitivity of the immune system to environmental toxins and the elicitation of immune reactions by various substances. The importance of fish as a
0 views • 25 slides
Understanding Antiemetic Screening Models in Pharmaceutical Science
Explore the fascinating world of antiemetic screening models in pharmaceutical science, covering topics such as the pathogenesis of vomiting, choice of emetogens, commonly used animals, parameters assessed, screening models, and more. Learn about drug-induced emesis models and the critical parameter
0 views • 25 slides
Exploration of Endpoints in Clinical Trials for Alcohol Use Disorder
This presentation discusses the exploration of endpoints in pivotal clinical trials to treat Alcohol Use Disorder (AUD), focusing on Primary Alcohol Drinking Endpoints like PSNHDD. Evidence supporting PSNHDD as a primary endpoint includes clinical benefit data from alcohol clinical trials and epidem
0 views • 54 slides
Understanding Pain, Distress, and Humane Endpoints in Animal Research
Explore the concepts of pain, distress, and humane endpoints in animals through a training program aimed at researchers developing protocols for the welfare of laboratory animals. The program includes pre- and post-assessments to gauge knowledge and learning outcomes, covers scenarios illustrating c
0 views • 19 slides
Clinical Cases Review: Neurological, Toxicological, and Orthopedic Presentations
Explore a collection of intriguing clinical cases including neurological symptoms, toxic ingestion, loss of consciousness, and orthopedic injuries. From CT findings to treatment modalities, delve into differential diagnoses, imaging investigations, risk factors, complications, and management strateg
0 views • 13 slides
Overview of PaNOSC Workshop API Endpoints & Data Structures
This project discusses the API endpoints and data structures from the PaNOSC Workshop, focusing on reviewing use cases, required search results/data, actors involved, and the design of endpoints reflecting proposal/experiment processes. It covers detailed discussions on data models, instrument setup
0 views • 19 slides
Nuclear Receptor-Mediated Toxicity: Molecular Insights and Implications
TOXICOLOGY research on Nuclear Receptor-Mediated Toxicity by Prof. Zdeněk Dvořák delves into the evidence, molecular properties, structures, and signaling pathways of nuclear receptors such as Aryl Hydrocarbon Receptor (AhR). Detailed information on the impact of AhR-mediated toxicity, including
0 views • 19 slides
Understanding Skin Sensitisation through Adverse Outcome Pathways (AOP)
The Adverse Outcome Pathway (AOP) for Skin Sensitisation provides a mechanistic framework linking Molecular Initiating Events (MIE) to Adverse Outcomes (AO) through Key Events (KE) and Key Event Relationships (KER). AOPs offer a transparent justification for toxicological predictions and play a vita
0 views • 21 slides
Algorithm for Determining Endpoints in Speech Recognition
This article discusses an algorithm proposed by L.R. Rabiner and M.R. Sambur in 1975 for determining endpoints in isolated utterances. The algorithm focuses on detecting word boundaries in speech through the recognition of silence, which can lead to reduced processing load and increased convenience,
0 views • 22 slides
IGEL Universal Management Suite - Efficient Endpoint Control Solution
IGEL Universal Management Suite (UMS) is a comprehensive system that empowers IT professionals with easy control over all endpoints. Included features like centralized installation, configuration, and update management make UMS a versatile tool for managing IGEL Zero Clients and third-party endpoint
0 views • 25 slides
Understanding Clinical Trial Endpoints and Regulatory Basis
Eugene J. Sullivan, MD, explains the importance of establishing efficacy in clinical trials based on substantial evidence from well-controlled trials. The discussion includes primary endpoints for Phase 3 trials, legal and regulatory requirements, and the significance of clinically meaningful effect
0 views • 21 slides
Guidelines for Scientific Endpoints and Humane Interventions in Animal Research
These guidelines outline the identification of scientific endpoints, humane intervention points, and cumulative endpoints in animal research. They emphasize the need for protocols approved by animal care committees, consideration of welfare-appropriate endpoints, and adaptation of endpoints during t
0 views • 17 slides
Toxicological Review of Ethyl Tertiary Butyl Ether (ETBE) by Japan Petroleum Energy Center (JPEC)
The Japan Petroleum Energy Center (JPEC) conducted extensive studies on Ethyl Tertiary Butyl Ether (ETBE) to assess its toxicity, carcinogenicity, and health risks. The research concluded that the use of 7% ETBE-blended gasoline in Japan does not pose significant human health risks through oral or i
0 views • 7 slides
Advancing In Vivo Toxicity Prediction Beyond Modeling
Explore the challenges and opportunities in predicting in vivo toxicity beyond traditional models. Learn about confidence in toxicity prediction, recently discontinued drugs due to safety concerns, and the importance of recognizing toxicological signals in preclinical stages. Discover how computatio
0 views • 27 slides
Understanding Inhalant Abuse: Risks, Effects, and Prevention
Inhalant abuse is a widespread issue, with volatile substances being inhaled to achieve psychoactive effects. This form of substance abuse poses significant toxicological and social hazards, often affecting marginalized populations such as neglected street children. The accessibility, affordability,
0 views • 44 slides
Understanding and Minimizing Pain and Distress in Research Protocols
This content explores the importance of reviewing research protocols to minimize pain and distress in animal experiments. It covers defining pain, distress, experimental and humane endpoints, evaluating management strategies, and ensuring ethical practices. It also includes a quick exercise to asses
0 views • 11 slides